Facebook Twitter

Moderna to mix COVID, flu vaccines together in new trial

Moderna said its vaccine is still under development.

SHARE Moderna to mix COVID, flu vaccines together in new trial
Vials of Moderna’s COVID-19 vaccines sit on a table.

Vials of Moderna’s COVID-19 vaccines sit on a table at the Mountain America Exposition Center in Sandy on Tuesday, May 18, 2021.

Scott G Winterton, Deseret News

Moderna announced on Thursday that it is developing a one-dose vaccine booster shot that would protect people against COVID-19 and the seasonal flu.

Moderna to mix COVID, flu vaccines

The company said the new vaccine — called mRNA-1073 — mixes the current COVID-19 vaccine from Moderna and a flu shot that’s still being developed.

  • “Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” CEO Stephane Bancel said in a statement. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”
  • Moderna said it is developing a vaccine for the respiratory syncytial virus (RSV), too.

Novavax creates single COVID, flu vaccine

The news comes one day after COVID-19 vaccine developer Novavax said it had started a trial for a single shot that would combine flu and COVID-9 vaccines, too, Reuters reports.

The participants in the trial will be given the mixed shot of the NVX-CoV2373 COVID-19 vaccine and the NanoFlu influenza vaccines, as I wrote for the Deseret News.

  • “Combination of these two vaccines ... may lead to greater efficiencies for the health care system and achieve high levels of protection against COVID-19 and influenza with a single regimen,” Gregory Glenn, president of research and development at Novavax, said in a statement, according to Reuters.